We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
Cap. Flow
+$513M
Cap. Flow %
6.13%
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.52%
2 Technology 13.89%
3 Financials 12.78%
4 Industrials 11.24%
5 Healthcare 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
1101
Chubb
CB
$140B
$796K 0.01%
5,954
-59,084
-91% -$7.99M
RDNT icon
1102
RadNet
RDNT
$4.84B
$796K 0.01%
52,900
+4,419
+9% +$63.1K
SAFM
1103
DELISTED
Sanderson Farms Inc
SAFM
$793K 0.01%
+7,675
New +$793K
LEXEA
1104
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$790K 0.01%
16,800
+10,477
+166% +$490K
PEGI
1105
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$789K 0.01%
+39,731
New +$767K
MDP
1106
DELISTED
Meredith Corporation
MDP
$786K 0.01%
+15,400
New +$805K
BL icon
1107
BlackLine
BL
$1.69B
$783K 0.01%
+13,874
New +$691K
CHSP
1108
DELISTED
Chesapeake Lodging Trust
CHSP
$779K 0.01%
+24,279
New +$787K
OEC icon
1109
Orion
OEC
$394M
$771K 0.01%
24,021
+5,853
+32% +$194K
DF
1110
DELISTED
Dean Foods Company
DF
$766K 0.01%
107,817
+11,174
+12% +$97.7K
ARDX icon
1111
Ardelyx
ARDX
$1.24B
$765K 0.01%
175,877
+138,077
+365% +$575K
COLL icon
1112
Collegium Pharmaceutical
COLL
$1.14B
$765K 0.01%
51,900
+18,100
+54% +$321K
MYGN icon
1113
Myriad Genetics
MYGN
$530M
$765K 0.01%
+16,639
New +$740K
ARLO icon
1114
Arlo Technologies
ARLO
$1.4B
$762K 0.01%
+52,544
New +$982K
GNK icon
1115
Genco Shipping & Trading
GNK
$1.17B
$761K 0.01%
54,353
-11,894
-18% -$168K
NERV icon
1116
Minerva Neurosciences
NERV
$188M
$759K 0.01%
7,555
+2,967
+65% +$223K
DRNA
1117
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$757K 0.01%
+49,593
New +$722K
LJPC
1118
DELISTED
La Jolla Pharmaceutical Company
LJPC
$757K 0.01%
37,602
+16,202
+76% +$423K
GTS
1119
DELISTED
Triple-S Management Corporation
GTS
$754K 0.01%
41,939
+24,812
+145% +$656K
OII icon
1120
Oceaneering
OII
$5.25B
$753K 0.01%
+27,270
New +$727K
PRI icon
1121
Primerica
PRI
$9.81B
$753K 0.01%
+6,243
New +$724K
WCN
1122
Waste Connections
WCN
$42.8B
$752K 0.01%
+9,431
New +$740K
AX icon
1123
Axos Financial
AX
$5.45B
$750K 0.01%
21,818
+14,351
+192% +$551K
AKBA icon
1124
Akebia Therapeutics
AKBA
$327M
$749K 0.01%
84,863
+4,683
+6% +$41.9K
GWPH
1125
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$748K 0.01%
+4,332
New +$625K

Similar funds

Squarepoint's Q3 2018 Portfolio in Review

As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.

  • Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
  • Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
  • Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
  • Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
  • Squarepoint opened 687 new positions and closed 456 in Q3 2018.
  • Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.